About LeMaitre Vascular, Inc
LeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide. It offers angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries or veins; occlusion catheters that temporarily occlude the blood flow; perfusion catheters to perfuse the blood and other fluids into the vasculature; and thrombectomy catheters, which features a silicone balloon for removing thrombi in the venous system. The company also provides carotid shunts that temporarily shunt the blood to the brain during the removal of plaque from the carotid artery in a carotid endarterectomy surgery; powered phlebectomy devices to remove varicose veins; and radiopaque tape, a medical-grade tape applied to the skin that enables interventionists to cross-refer between the inside and the outside of a patient’s body, and allows them to locate tributaries or lesions beneath the skin. In addition, it offers remote endarterectomy devices to remove plaque from arteries in the leg; valvulotomes, which cut valves in the saphenous vein to function as an artery to carry blood past diseased arteries to the lower leg or the foot; and vascular grafts to bypass or replace diseased arteries. Further, the company provides vascular patches, which are used for closure of vessels after surgical intervention; closure systems to attach vessels to one another with titanium clips instead of sutures; and surgical glue. It markets its products through a direct sales force and distributors. The company was formerly known as Vascutech, Inc. and changed its name to LeMaitre Vascular, Inc. in April 2001. LeMaitre Vascular, Inc. was incorporated in 1983 and is headquartered in Burlington, Massachusetts. Address: 63 Second Avenue, Burlington, MA, United States, 01803
LeMaitre Vascular, Inc News and around…
Latest news about LeMaitre Vascular, Inc (LMAT) common stock and company :
BURLINGTON, Mass., May 16, 2022 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it is participating in two upcoming investor conferences. JJ Pellegrino, Chief Financial Officer, will present at the UBS Global Healthcare Conference on Monday, May 23, 2022 at the Lotte New York Palace in New York City. The company’s presentation is scheduled at 2:00 PM ET. David Roberts, President, will present at the Jefferies in the Jefferies Healthcare Conference on Wednesday, Jun
It looks like LeMaitre Vascular, Inc. ( NASDAQ:LMAT ) is about to go ex-dividend in the next two days. The ex-dividend...
LeMaitre (LMAT) delivered earnings and revenue surprises of -3.57% and 1.84%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
BURLINGTON, Mass., April 28, 2022 (GLOBE NEWSWIRE) -- LeMaitre (Nasdaq:LMAT), a provider of vascular devices, implants and services, today reported Q1 2022 results, announced a $0.125/share quarterly dividend and provided guidance. Q1 2022 Financial Results Sales of $39.6mm, +10% (+13% organic) vs. Q1 2021Op. income of $7.9mm, +0%Op. margin of 20%Net income of $6.0mm, +2%Earnings of $0.27 per diluted share, -4%Cash and investments +$0.9mm to $70.9mm Q1 2022 sales growth was driven by Artegraft,
One simple way to benefit from the stock market is to buy an index fund. But if you pick the right individual stocks...
BURLINGTON, Mass., April 15, 2022 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its first quarter 2022 financial results on Thursday, April 28, 2022, after the market close. The company has scheduled a conference call for 5:00 PM ET the same day to discuss the results, business highlights, and company outlook. Access to the live call is available by dialing 844-239-5284 (+1-512-961-6497 for international callers), passcode 8054167. The call can al
Dividend growth investors are arguably best-served by building a diversified portfolio of quality stocks in industries poised for promising future growth. Investors would have to look long and hard to find a stock that better fits this description than the small-cap medical devices stock LeMaitre Vascular (NASDAQ: LMAT). Let's take a closer look at LeMaitre's fundamentals and valuation to decide.
BURLINGTON, Mass., April 01, 2022 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that JJ Pellegrino, Chief Financial Officer, will present at the 21st Annual Needham Virtual Healthcare Conference on Thursday, April 14, 2022, at 10:15 AM ET. LeMaitre is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures and markets disposable an
Today we'll do a simple run through of a valuation method used to estimate the attractiveness of LeMaitre Vascular...
BURLINGTON, Mass., March 21, 2022 (GLOBE NEWSWIRE) -- LeMaitre (Nasdaq:LMAT), a provider of vascular devices, implants and services, today announced that it has joined the NASDAQ US Broad Dividend Achievers Index. The index is comprised of US securities with at least ten consecutive years of increasing annual regular dividend payments. In 2011, LeMaitre’s first year of dividends, the annual payout per share was $0.08. In 2021, LeMaitre paid $0.44 per share, representing 18.6% compounded annual d
BURLINGTON, Mass., March 01, 2022 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will be participating in four upcoming investor conferences in March. 34th Annual Roth Conference 2022Monday, March 14, 2022The Ritz Carlton, Laguna Niguel located in Dana Point, CADavid Roberts, President, will present at 1:30 PM PT (4:30pm ET) Oppenheimer 32nd Annual Healthcare Conference (Virtual)Wednesday, March 16, 2022JJ Pellegrino, Chief Financial Officer, will prese
Like a puppy chasing its tail, some new investors often chase 'the next big thing', even if that means buying 'story...
LeMaitre (LMAT) delivered earnings and revenue surprises of -9.68% and 0.66%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
BURLINGTON, Mass., Feb. 24, 2022 (GLOBE NEWSWIRE) -- LeMaitre (Nasdaq:LMAT), a provider of vascular devices, implants and services, today reported Q4 2021 results, announced a $0.125/share quarterly dividend (+14%) and provided guidance. Q4 2021 Financial Results Sales of $39.5mm, +5% (+6% organic) vs. Q4 2020Op. income of $8.3mm, -13%Op. margin of 21%Net income of $6.2mm, -12%Earnings of $0.28 per diluted share, -18%Cash and investments +$2.9mm to $70.0mm Q4 2021 sales were driven by bovine gra
NuVasive (NUVA) delivered earnings and revenue surprises of -14.89% and 1.50%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
LeMaitre (LMAT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
BURLINGTON, Mass., Feb. 11, 2022 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its fourth quarter 2021 financial results on Thursday, February 24, 2022, after the market close. The company has scheduled a conference call for 5:00 PM ET the same day to discuss the results, business highlights, and company outlook. Access to the live call is available by dialing 800-773-2954 (+1-847-413-3731 for international callers), passcode 50283055. The call ca
BURLINGTON, Mass., Feb. 09, 2022 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that JJ Pellegrino, Chief Financial Officer, will present at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference on Wednesday, February 16, 2022, at 10:30 AM ET. LeMaitre is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures
Investment company Knowledge Leaders Capital, LLC (Current Portfolio) buys MaxLinear Inc, Broadcom Inc, Omnicell Inc, Amphenol Corp, NetApp Inc, sells Schwab U.S.
With its stock down 20% over the past three months, it is easy to disregard LeMaitre Vascular (NASDAQ:LMAT). However...
LeMaitre Vascular, Inc (LMAT) is a NASDAQ Common Stock listed in Common Stock, Healthcare, Medical Instruments & Supplies
